- Home
- ELAN
as 07-26-2024 4:00pm EST
Elanco Animal Health Inc is an animal health company that is engaged in innovating, developing, manufacturing, and marketing products for companion and food animals. Geographically, the company's operations are conducted globally and sell its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production. The company's product portfolio of approximately 200 brands.
| Founded: | 1954 | Country: | United States |
| Employees: | N/A | City: | GREENFIELD |
| Market Cap: | 6.6B | IPO Year: | 2018 |
| Target Price: | $17.50 | AVG Volume (30 days): | 5.8M |
| Analyst Decision: | Buy | Number of Analysts: | 6 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -2.65 | EPS Growth: | N/A |
| 52 Week Low/High: | $8.52 - $18.80 | Next Earning Date: | 08-08-2024 |
| Revenue: | $4,365,000,000 | Revenue Growth: | -1.76% |
| Revenue Growth (this year): | 3.8% | Revenue Growth (next year): | 4.60% |
Stock Insider Trading Activity of Elanco Animal Health Incorporated (ELAN)
| Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| DOYLE WILLIAM F | ELAN | Director | May 21 '24 | Buy | $16.98 | 15,000 | $254,700.00 | 76,330 | SEC Form 4 |
| DOYLE WILLIAM F | ELAN | Director | Mar 8 '24 | Buy | $16.30 | 15,000 | $244,500.00 | 61,330 | SEC Form 4 |
| Harrington Michael J | ELAN | Director | Mar 8 '24 | Buy | $16.29 | 3,100 | $50,493.73 | 77,594 | SEC Form 4 |
| HOOVER R DAVID | ELAN | Director | Mar 6 '24 | Buy | $16.14 | 20,000 | $322,808.00 | 185,000 | SEC Form 4 |
Latest Elanco Animal Health Incorporated News
ELAN Breaking Stock News: Dive into ELAN Ticker-Specific Updates for Smart Investing
Zacks
4 days ago
Elanco (ELAN) Stock Declines After Sale of Aqua Business
PR Newswire
9 days ago
Elanco Confirms Date and Conference Call for Second Quarter 2024 Financial Results Announcement
Argus Research
10 days ago
Analyst Report: Elanco Animal Health Inc
Argus Research
10 days ago
Market Digest: MS, PNC, SCHW, UNH, ELAN
MT Newswires
17 days ago
Merck's Animal Health Division Completes $1.3 Billion Acquisition of Elanco Animal Health's Aqua Business
PR Newswire
17 days ago
Elanco Completes Sale of Aqua Business
MT Newswires
a month ago
Piper Sandler Adjusts Price Target on Elanco Animal Health to $16 From $19, Maintains Neutral Rating
MT Newswires
a month ago
Barclays Cuts Price Target on Elanco Animal Health to $21 From $23, Maintains Overweight Rating
Compare ELAN vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ELAN Elanco Animal Health Incorporated - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.